Business News Johnson & Johnson vs Abbott similispharma@gmail.comAugust 12, 20260 Business NewsBy Arjun MehtaAugust 12, 20269 min read Key Takeaways Earnings reveal J&J's strong pharmaceutical sales Abbott's medical devices drive…
Business News Elevance Health Stocks Soar similispharma@gmail.comJuly 31, 20260 Business NewsBy Kavita NairJuly 31, 20268 min read Key Takeaways Investors boost Elevance Health's shares Earnings surge 14% in Q2…
Entrepreneurship Edwards Lifesciences Revenue Soars similispharma@gmail.comJuly 29, 20260 EntrepreneurshipBy Arjun MehtaJuly 29, 20268 min read Key Takeaways Investors flock to Edwards Lifesciences after 47% TMTT revenue surge TMTT…
Business News Abbott Stock Surges 5 Percent similispharma@gmail.comJuly 18, 20260 Business NewsBy Kavita NairJuly 18, 20266 min read Key Takeaways Significant market developments around Why Abbott Stock Jumped Today are…
Business News ICON Public Limited Company Falls similispharma@gmail.comJuly 9, 20260 Business NewsBy Kavita NairJuly 9, 20267 min read Key Takeaways Investors dumped ICON shares, wiping out billions in value. Earnings…
Business News Pfizer Dividend Stocks Pay $5000 similispharma@gmail.comJune 29, 20260 Business NewsBy Priya SharmaJune 29, 20267 min read Key Takeaways Investors require 942 Pfizer shares to earn $5,000 yearly Pfizer…
Stock Market DaVita Stock Surges Ahead similispharma@gmail.comJune 23, 20260 Stock MarketBy Priya SharmaJune 23, 20269 min read Key Takeaways Analysts attribute DaVita's success to innovative kidney care Goldman Sachs…
Investments Trump Invests in Healthcare Stocks similispharma@gmail.comJune 21, 20260 InvestmentsBy Rohan DesaiJune 21, 20264 min read Key Takeaways Investors flock to healthcare stocks amid Value-Based Care trend Trump buys…
Startups Citi Undervalues Abbott Labs similispharma@gmail.comJune 20, 20260 StartupsBy Kavita NairJune 20, 20267 min read Key Takeaways Analysts upgrade Abbott's outlook due to diversification Investors recognize Abbott's strong…
Investments Quest Diagnostics Stock Lags S&P 500 similispharma@gmail.comJune 20, 20260 InvestmentsBy Priya SharmaJune 20, 20268 min read Key Takeaways Investors analyze Quest Diagnostics' underperformance Stock prices lag behind S&P 500…